+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2019

  • ID: 4898178
  • Report
  • December 2019
  • Region: Global
  • 110 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • AIS Inc.
  • Boston Scientific Corp
  • CardiaLen, Inc.
  • Coridea, LLC
  • Johns Hopkins University
  • Kenergy Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2019“ provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AIS Inc.
  • Boston Scientific Corp
  • CardiaLen, Inc.
  • Coridea, LLC
  • Johns Hopkins University
  • Kenergy Inc.

1 Introduction
1.1 Implantable Cardioverter Defibrillators (ICD) Overview
2 Products under Development
2.1 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
2.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
2.3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
2.4 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
2.5 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
2.6 Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
3 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products under Development by Companies
3.1 Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
3.2 Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
4 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview
4.1 AIS Inc. Company Overview
4.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.2 Boston Scientific Corp Company Overview
4.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
4.3 CardiaLen, Inc. Company Overview
4.3.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.4 Coridea, LLC Company Overview
4.4.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
4.5 InnerPulse Inc (Inactive) Company Overview
4.5.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.6 Johns Hopkins University Company Overview
4.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
4.7 Kenergy Inc. Company Overview
4.7.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
4.8 Massachusetts General Hospital Company Overview
4.8.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
4.9 Max Planck Institute for Dynamics and Self-Organization Company Overview
4.9.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
4.10 Medtronic plc Company Overview
4.10.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
4.11 MicroPort CRM Company Overview
4.11.1 MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
4.12 Smartwave Medical Ltd (Inactive) Company Overview
4.12.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5 Implantable Cardioverter Defibrillators (ICD)- Recent Developments
5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
5.3 Oct 30, 2019: CONMED announces third quarter 2019 financial results
5.4 Oct 28, 2019: Philips delivers Q3 sales of EUR 4.7 billion, with 6% comparable sales growth, EUR 211 million income from continuing operations and an Adjusted EBITA margin of 12.4%
5.5 Oct 28, 2019: Philips' third quarter results 2019
6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Table 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
Table 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
Table 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
Table 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
Table 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
Table 7: Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development
Table 8: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Table 9: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Guardian - Product Status
Table 11: Guardian - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: EMBLEM MRI S-ICD System - Aged Patients - Product Status
Table 14: EMBLEM MRI S-ICD System - Aged Patients - Product Description
Table 15: S-ICD System 1.5 - Product Status
Table 16: S-ICD System 1.5 - Product Description
Table 17: S-ICD System 2.0 - Product Status
Table 18: S-ICD System 2.0 - Product Description
Table 19: VITALITY NXT Defibrillator - Product Status
Table 20: VITALITY NXT Defibrillator - Product Description
Table 21: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 22: S-ICD System 2.0 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing
Table 23: S-ICD System 1.5 - A Prospective Randomised Comparative Trial of Subcutaneous Implantable Cardioverter-defibrillator Implantation with and without Defibrillation Testing
Table 24: EMBLEM MRI S-ICD System - Aged Patients - Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)
Table 25: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 26: CardiaLen Device - Atrial Fibrillation - Product Status
Table 27: CardiaLen Device - Atrial Fibrillation - Product Description
Table 28: CardiaLen, Inc. - Ongoing Clinical Trials Overview
Table 29: CardiaLen Device - Atrial Fibrillation - An International Clinical Feasibility Study to Evaluate the Safety and Performance of Low-Energy Unpinning Termination Therapy in Patients with VT/VF
Table 30: CardiaLen Device - Atrial Fibrillation - Unpinning Pulse Termination Therapy for Ventricular Tachyarrhythmias
Table 31: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 32: Table-Top PaDe System - Product Status
Table 33: Table-Top PaDe System - Product Description
Table 34: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 35: PICD - Product Status
Table 36: PICD - Product Description
Table 37: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Cardiac Sock Electrode And Implantable Defibrillator System - Product Status
Table 39: Cardiac Sock Electrode And Implantable Defibrillator System - Product Description
Table 40: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Unconditional MRI Compatible Implantable Defibrillator - Product Status
Table 42: Unconditional MRI Compatible Implantable Defibrillator - Product Description
Table 43: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Status
Table 45: Implantable Cardioverter Defibrillator - Ventricular Arrhythmias - Product Description
Table 46: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Implantable Defibrillator - Product Status
Table 48: Implantable Defibrillator - Product Description
Table 49: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Chronicle ICD - Product Status
Table 51: Chronicle ICD - Product Description
Table 52: EV-ICD System - Product Status
Table 53: EV-ICD System - Product Description
Table 54: Medtronic plc - Ongoing Clinical Trials Overview
Table 55: Chronicle ICD - Benefits of ICD for the Primary Prevention in Patients with Valvular Cardiomyopathy
Table 56: EV-ICD System - Benefits of ICD for the Primary Prevention in Patients with Valvular Cardiomyopathy
Table 57: EV-ICD System - Extravascular ICD Pilot Study
Table 58: EV-ICD System - Extravascular ICD Pivotal Study (EV ICD)
Table 59: MicroPort CRM Pipeline Products & Ongoing Clinical Trials Overview
Table 60: NAVIGO 4LV 2D - Product Status
Table 61: NAVIGO 4LV 2D - Product Description
Table 62: NAVIGO 4LV ARC - Product Status
Table 63: NAVIGO 4LV ARC - Product Description
Table 64: NAVIGO 4LV PILOT - Product Status
Table 65: NAVIGO 4LV PILOT - Product Description
Table 66: MicroPort CRM - Ongoing Clinical Trials Overview
Table 67: NAVIGO 4LV 2D - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 68: NAVIGO 4LV ARC - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 69: NAVIGO 4LV PILOT - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector
Table 70: Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Fully Automatic Implantable Atrial Defibrillator - Product Status
Table 72: Fully Automatic Implantable Atrial Defibrillator - Product Description
Table 73: Glossary
List of Figures
Figure 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development
Figure 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment
Figure 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory
Figure 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path
Figure 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date
Figure 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AIS Inc.
  • Boston Scientific Corp
  • CardiaLen, Inc.
  • Coridea, LLC
  • Johns Hopkins University
  • Kenergy Inc.
  • Massachusetts General Hospital
  • Max Planck Institute for Dynamics and Self-Organization
  • Medtronic plc
  • MicroPort CRM
Note: Product cover images may vary from those shown